Roche
 Roche
Roche is a leading healthcare company with a
uniquely broad spectrum of innovative solutions. For more than 100 years, Roche
have been active in the discovery, development, manufacture and marketing of
novel healthcare solutions. Roche products and services address prevention,
diagnosis and treatment of diseases, thus enhancing well-being and quality of
life.
Roche focus is not just the diagnosis and treatment of manifest
disease. The integrated healthcare approach is increasingly offering ways of
identifying and targeting diseases early, when their damaging effects can still
be prevented.
Arranged in two operative divisions, our global mission
today and tomorrow is to create exceptional added value in healthcare. These
two units are: Pharmaceuticals and Diagnostics
Roche Pharmaceuticals
When
Fritz Hoffmann founded F. Hoffmann-La Roche & Co. in 1896, he realised what
was then a revolutionary idea - producing medicines on an industrial scale
outside the pharmacy and selling them on the international market. Innovation
has been one of Roche's hallmarks ever since, and many of our pharmaceutical
products have become milestones in drug therapy. Upon these products we built
our present world leadership in the hospital pharmacy market.
At
Roche’s Pharmaceuticals Division, we view continuous innovation as the
most promising way to bring new medicines to the patient. Looking to the
future, our long-standing expertise in medicinal chemistry and biotechnology
have put us in an excellent position to exploit the huge potential of molecular
medicine.
Roche has a long history in the discovery, development,
production and marketing of cost-effective prescription drugs that often
represent true breakthroughs in combating human diseases.
Focusing on
prescription drugs, Roche Pharmaceuticals currently engage in the following
areas (amongst others):
Anaemia, Cardiovascular diseases, Central
nervous system, Dermatology, Infectious diseases, Inflammatory and autoimmune
disease,s Metabolic disorder,s Oncology, Respiratory diseases, Transplantation
and Virology.
Roche Pharmaceuticals in the
UK
Part of one of the world’s leading healthcare companies,
Roche is proud to have been a part of the UK’s healthcare environment
since 1908 and today employs around 1,800 people in the UK.
In a world
where most medical conditions remain incurable, Roche aims to make a difference
with treatments that are targeted to the needs of individuals.
Roche
Pharmaceuticals aim to develop and deliver solutions that have the greatest
impact on people’s lives. At the forefront of the fight against cancer,
Roche focuses on providing better targeted treatment. Roche is also a leading
player in the field of viral diseases with innovative therapies for HIV,
hepatitis C and influenza.
Roche has a long-term commitment to
transplantation, providing treatments that increase the survival of
transplanted organs. Another of our therapies combats the anaemia that causes
chronic fatigue in so many kidney patients on dialysis or before they need
dialysis.
Roche helps healthcare professionals tackle the growing
problem of obesity with an innovative treatment and in the cardiovascular arena
Roche medicines help patients who have heart attacks or who live with heart
failure. This innovative portfolio is provided in the UK by our teams based at
Welwyn Garden City in Hertfordshire.
The UK also plays a crucial role in
driving forward Roche’s pipeline of important new treatments in areas
including transplantation, cancer, rheumatoid arthritis, osteoporosis and viral
diseases. Our site at Welwyn Garden City in Hertfordshire is a globally
important centre for the development of new Roche medicines, being one of just
three Roche sites around the world which manage global clinical trials to
assess the safety and efficacy of new medicines.
Further Roche Pharmaceuticals
information
www.rocheuk.com/
www.roche.com
Page last updated:
27.04/06 |
